Annual D&A
$214.86M$19.64M-8.38%
Summary
- Current Value
- As of today, EXAS annual D&A is $214.86M, down -8.38% on
- Historical Performance
- EXAS annual D&A is up +4.21% over the past 3 years, and up +285.92% over the past 5 years
- All-Time High Comparison
- EXAS annual D&A is currently -8.38% below its historical high of $234.50M set on
- 3-Year Low Comparison
- EXAS annual D&A is at its 3-year low
- Sector Comparison
- EXAS annual D&A is higher than 92.15% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $214.86M | -8.4% | +4.2% | +285.9% | +10000.0% | |
| Quarterly D&A | $55.88M | +2.0% | +0.3% | +18.1% | +10000.0% | |
| TTM D&A | $218.37M | -2.0% | -3.0% | +33.6% | +10000.0% | |
| Price | $102.11 | +80.2% | +73.6% | -22.1% | +1585.0% | |
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual Total Expenses | $3.79B | +40.1% | +60.3% | +294.4% | +10000.0% | |
| Annual Operating Expenses | $2.11B | +2.2% | +8.7% | +159.1% | +10000.0% | |
| Annual Revenue | $2.76B | +10.4% | +56.1% | +214.8% | +10000.0% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $234.50M | -8.4% | |
| 5Y | $234.50M | -8.4% | |
| All | $234.50M | -8.4% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $214.86M | at low | |
| 5Y | $179.08M | N/A | +20.0% |
| All | $80.00K | >+9999.0% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of EXAS?
As of today, EXAS annual D&A is $214.86M
What is 1-year change in EXAS annual D&A?
EXAS annual D&A is down -8.38% year-over-year
What is 3-year change in EXAS annual D&A?
EXAS annual D&A is up +4.21% over the past 3 years
How far is EXAS annual D&A from its all-time high?
EXAS annual D&A is currently -8.38% below its historical high of $234.50M set on December 31, 2023
How does EXAS annual D&A rank versus sector peers?
EXAS annual D&A is higher than 92.15% of companies in Healthcare sector
When is EXAS next annual earnings release?
The next annual earnings release for EXAS is on
Quarterly D&A
$55.88M$599.00K+1.08%
Summary
- Current Value
- As of today, EXAS quarterly D&A is $55.88M, up +1.08% on
- Historical Performance
- EXAS quarterly D&A is up +2.03% year-over-year, and up +0.25% over the past 3 years
- All-Time High Comparison
- EXAS quarterly D&A is currently -9.55% below its historical high of $61.78M set on
- 3-Year Low Comparison
- EXAS quarterly D&A is +5.44% above its 3-year low of $53.00M reached on
- Sector Comparison
- EXAS quarterly D&A is higher than 91.33% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $55.88M | +1.1% | +2.0% | +0.3% | +18.1% | |
| Annual D&A | $214.86M | – | -8.4% | +4.2% | +285.9% | |
| TTM D&A | $218.37M | +0.5% | -2.0% | -3.0% | +33.6% | |
| Price | $102.11 | +71.7% | +80.2% | +73.6% | -22.1% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly Total Expenses | $870.33M | +7.2% | +16.5% | +29.6% | +42.5% | |
| Quarterly Operating Expenses | $567.65M | +1.4% | +9.7% | +19.2% | +100.2% | |
| Quarterly Revenue | $850.74M | +4.9% | +20.1% | +62.6% | +108.3% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $55.88M | at high | |
| 3Y | $61.15M | -8.6% | |
| 5Y | $61.78M | -9.6% | |
| All | $61.78M | -9.6% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $53.15M | N/A | +5.2% |
| 3Y | $53.00M | +5.4% | |
| 5Y | $44.50M | N/A | +25.6% |
| All | -$59.00K | >+9999.0% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of EXAS?
As of today, EXAS quarterly D&A is $55.88M
What is EXAS quarterly D&A most recent change?
EXAS quarterly D&A was up +1.08% on September 30, 2025
What is 1-year change in EXAS quarterly D&A?
EXAS quarterly D&A is up +2.03% year-over-year
How far is EXAS quarterly D&A from its all-time high?
EXAS quarterly D&A is currently -9.55% below its historical high of $61.78M set on June 30, 2022
How does EXAS quarterly D&A rank versus sector peers?
EXAS quarterly D&A is higher than 91.33% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on
TTM D&A
$218.37M$1.11M+0.51%
Summary
- Current Value
- As of today, EXAS TTM D&A is $218.37M, up +0.51% on
- Historical Performance
- EXAS TTM D&A is down -2.01% year-over-year, and down -3.00% over the past 3 years
- All-Time High Comparison
- EXAS TTM D&A is currently -6.88% below its historical high of $234.50M set on
- 3-Year Low Comparison
- EXAS TTM D&A is +1.64% above its 3-year low of $214.86M reached on
- Sector Comparison
- EXAS TTM D&A is higher than 91.42% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $218.37M | +0.5% | -2.0% | -3.0% | +33.6% | |
| Annual D&A | $214.86M | – | -8.4% | +4.2% | +285.9% | |
| Quarterly D&A | $55.88M | +1.1% | +2.0% | +0.3% | +18.1% | |
| Price | $102.11 | +71.7% | +80.2% | +73.6% | -22.1% | |
| TTM SG&A | -$18.32B | -1124.4% | -1213.2% | -1215.0% | -1889.5% | |
| TTM Revenue | $3.08B | +4.8% | +14.5% | +53.7% | +133.4% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $218.37M | at high | |
| 3Y | $234.50M | -6.9% | |
| 5Y | $234.50M | -6.9% | |
| All | $234.50M | -6.9% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $214.86M | N/A | +1.6% |
| 3Y | $214.86M | +1.6% | |
| 5Y | $179.08M | N/A | +21.9% |
| All | $21.00K | >+9999.0% |
TTM D&A History
FAQ
What is the current TTM D&A of EXAS?
As of today, EXAS TTM D&A is $218.37M
What is EXAS TTM D&A most recent change?
EXAS TTM D&A was up +0.51% on September 30, 2025
What is 1-year change in EXAS TTM D&A?
EXAS TTM D&A is down -2.01% year-over-year
How far is EXAS TTM D&A from its all-time high?
EXAS TTM D&A is currently -6.88% below its historical high of $234.50M set on December 31, 2023
How does EXAS TTM D&A rank versus sector peers?
EXAS TTM D&A is higher than 91.42% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on
Data Sources & References
- EXAS Official Website www.exactsciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1124140/000112414025000091/0001124140-25-000091-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1124140/000112414025000020/0001124140-25-000020-index.htm
- EXAS Profile on Yahoo Finance finance.yahoo.com/quote/EXAS
- EXAS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exas